Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Karnov Group releases industry report ‘Future Lawyer 2021’

Mental health is a taboo according to Scandinavian legal professionalsToday Karnov Group Denmark, Norstedts Juridik and Karnov Group Norway are launching the industry report Future Lawyer 2021. The report is the largest of its kind in Scandinavia and is based on data from 3379 full time legal professionals from Denmark, Sweden and Norway. The data is gathered and analysed by the independent Swedish agency, Augur. “It is my hope that the insights reported this year will help strengthen the legal industry, whether you are employed in the public or corporate sector or at a law firm. My hope

Zengun Group AB (publ) INTERIM REPORT FOR 1 APRIL TO 30 JUNE 2021

“Our customers displayed their continued confidence in us during the quarter. Our order book and orders received are at record-high levels and we are now coming out of a period with low production rates.” Mick Salonen Högberg, Managing Director and CEOSECOND QUARTER · Net turnover amounted to MSEK 420.1 (709.9). · EBITDA totalled MSEK 22.3 (28.7), corresponding to an EBITDA margin of 5.3% (4.0). · Earnings before tax amounted to MSEK 6.7 (13.3). · Operating cash flow was MSEK -18.3 (62.7) · Orders received totalled MSEK 972 (320). FIRST SIX MONTHS · Net turnover

ZINZINO AB (PUBL): INTERIM REPORT SECOND QUARTER 2021

INCREASED PROFIT FORECAST AFTER ANOTHER STRONG QUARTERThe second quarter of 2021 was yet another quarter in which good sales growth was combined with high profitability. Total revenues in the Group increased by 18% and amounted to SEK 322.4 (274.3) million. EBITDA result amounted to SEK 33.4 (16.0) million for the quarter and the EBITDA margin amounted to 10.4% (5.8%). The margin improvement is achieved through economies of scale due to improved efficiency in IT systems, logistics and within the organization. During the quarter, sales started in India, and Malaysia achieved full market

Scout Gaming publishes Q2 2021: Total revenues increased 121% to SEKm 13.9

”We had a busy quarter with the Euro 2020 as the main focus for the Group. Operator Trading Index grew with 203%. Total revenues increased with 121% to SEKm 13.9. The active user base cross our network partners have continued to grow substantially. Compared to average monthly users of the second quarter last year we experienced a growth of 302%. Strategically, we strive to optimize our marketing to support long-term growth. We use the start of major events such as Premier League, Euros or World Cup as aggressive growth-drivers. The market leading Norwegian operator Norsk Tipping has soft-

Tradedoubler Interim Report January - June 2021

The second quarter April – June 2021 · Total revenue amounted to SEK 333 M (287) an increase of 16% or 21% adjusted for changes in exchange rates compared to the same period last year.  · Gross profit was SEK 67 M (64), an increase of 4% or 9% adjusted for changes in exchange rates. Gross margin was 20.2% (22.4).  · Operating costs excluding depreciation and change related items were SEK 51M (50), an increase of 1% or 4% adjusted for changes in exchange rates.  · EBITDA amounted to SEK 16 M (14). Adjusted for change related items, EBITDA was SEK 17 M (14).  ·

Vicore strengthens its management team

Gothenburg, August 27, 2021 - Vicore Pharma Holding AB (publ) (“Vicore”), a rare disease pharmaceutical company developing innovative medicines for fibrotic lung disorders such as idiopathic pulmonary fibrosis (IPF), today announces the addition of three experienced executives to its management team, strengthening business and commercial operations as the company’s research and development activities approach key commercial decision points.Åsa Magnusson will join as Vicore’s Chief Commercial Officer and Mikael Nygård will join as VP of Business Development, becoming part of an enlarged

Konecranes appoints Anneli Karkovirta Senior Vice President, Human Resources

KONECRANES PLC STOCK EXCHANGE RELEASE August 27, 2021 at 9:00 EEST Konecranes appoints Anneli Karkovirta Senior Vice President, Human Resources Konecranes has today appointed Anneli Karkovirta (b. 1963) Senior Vice President, Human Resources and Member of the Konecranes Leadership Team effective August 30, 2021. In her role she will be responsible for human resources, marketing & communications and sustainability and will report to Rob Smith, President and CEO. Karkovirta, currently Vice President, HR Business Area Industrial Equipment, corporate strategy projects and M&A, will

Transcom Holding AB (publ): Second quarter report 2021

Second quarter 2021 highlights · Revenue increased to 143.4 M€ (132.2) · EBITDA excluding non-recurring items* amounted to 12.5 M€ (14.7) · EBITDA margin excluding non-recurring items amounted to 8.7% (11.1%) · Operating cash flow amounted to -2.4 M€ (13.6) · Net debt/EBITDA* decreased to 3.7 (3.7) January-June 2021 · Revenue increased to 294.3 M€ (260.0) · EBITDA excluding non-recurring items* increased to 31.2 M€ (28.5) · EBITDA margin excluding non-recurring items amounted to 10.6% (11.0%) · Operating cash flow amounted to 9.3 M€ (20.9) · Net debt/

Interim report Q2 2021

January 1 - June 30 2021 · Net Sales SEK 18 506 · Operation profit SEK -5 836 196 · Profit after financial items SEK -5 782 823 · Earnings per share SEK -0,23 · Numbers of shares 25 293 518 April 1 - June 30 2021 · Net Sales SEK 18 506 · Operation profit SEK -3 623 549 · Profit after financial items SEK -3 570 176 · Earnings per share SEK -0,14 · Numbers of shares 25 293 518 Significant events during the report period (2021-01-01 - 2021-06-30) · Raytelligence is listed on the Stuttgart Stock Exchange, Germany · Receives initial order from Careteq,

Penneo realizes 61% ARR growth rate in 2021-H1 and improves ARR guidance for 2021

Company Announcement No. 19-2021Copenhagen, 27 August 2021 Financial report for the period 1 January 2021 - 30 June 2021 Key features 2021-H1 · Annual Recurring Revenue (ARR) increased 61% to 47.6M DKK end of 2021-H1 from 29.5M DKK in 2020-H1 · ARR from new customers increased by 5.3M DKK in 2021-H1 which is 83% higher than 2.9M DKK in 2020-H1 · Average Revenue Per Account (ARPA) increased by 29% compared to 2020-H1 · EBITDA amounted to negative 5.4M DKK as a result of the planned investments in future ARR growth · ARR guidance for 2021 is improved to 56-60M DKK

Changes to NCC’s Nomination Committee

Sussi Kvart, representing Handelsbanken Funds, will become a new member of NCC’s Nomination Committee. Peter Guve, representing AMF/AMF Funds, will leave the Nomination Committee on account of ownership changes.Following these changes, NCC’s Nomination Committee consists of Viveca Ax:son Johnson (Chairman of the Nomination Committee), Chairman of the Board of Nordstjernan AB; Simon Blecher, Asset Manager Carnegie Funds; Mats Gustafsson, Asset Manager Lannebo Funds; and Sussi Kvart, Handelsbanken Funds. Accordingly, the composition of the Nomination Committee reflects the ownership in NCC.

Baseload Capital Sweden AB (publ) today releases the results for the period 1 January – 30 June 2021

Interim report for the period 1 January – 30 June 2021 During the second quarter the focus has been on execution and business development in all of our active markets. · Profit/loss for the period was SEK -34.1 million, with revaluation of projects and loans to subsidiaries accounting for SEK -17.2 million, of which SEK -7.5 million consists of exchange rate differences as a result of a stronger Swedish krona. · In the US, the project company is still waiting for permission from the authorities to release geothermal water from the Wendel plant in a nearby stream, but the

Fellow Finance Plc’s half year review 2021

FELLOW FINANCE PLC COMPANY ANNOUNCEMENT 27.8.2021 8:00 AMVolume of intermediated loans has recovered to a growth path and we will start building a new innovative digital banking business  1.1.−30.6.2021 summary · Turnover was 5.5 million euros (5.8), decrease of 5.3% · Profit of the reporting period was -0.1 million euros (-0.7) · EBIT was 0.5 million euros (-0.1) · EBIT margin was 9.7% (-0.9) · Earnings per share (EPS) was -0.01 euros (-0.10) · Intermediated loan volume was approximately 90.7 million euros (69.1) · Intermediated loan volume grew 31% compared to

Green Landscaping Group Interim Report January-June 2021

27 August 2021 - 07:00 CEST “Substantial increase in sales, earnings and cash flow” April-June 2021 · Sales during the quarter amounted to SEK 794.4 (552.1) million, which is an increase of 43.9 percent*. Organic growth was 2.8 percent. · EBITA amounted to SEK 65.1 (46.5) million. It corresponds to an increase of 40.0 percent. · EBITA margin amounted to SEK 8.2 (8.4) percent. · Cash flow from operating activities amounted to SEK 104.2 (63.0) million. · Net debt amounted to SEK 913.3 (518.5) million. · Earnings per share were SEK 0.76 (0.82). Diluted earnings per

Nordic Nanovector ASA: Resultat for andre kvartal og første halvår 2021

Oslo, Norge, 27. august 2021 Nordic Nanovector ASA (OSE:NANOV) publiserer i dag resultatene for andre kvartal og første halvår 2021. Selskapets ledelse vil presentere resultatene i en direktesendt webcast i dag kl. 08.30. En lenke til webcasten er tilgjengelig på www.nordicnanovector.com Resultatrapporten og presentasjonen er også tilgjengelig på selskapet nettside under fanen: www.nordicnanovector.com/Investors & Media/Reports and Presentation/Interim Reports/2021 Et opptak av webcastsendingen vil bli lagt ut på denne siden i etterkant av presentasjonen. «Nordic Nanovector

Aros Bostad’s Six Month Report for January-June 2021 shows continuous growth, listing of ordinary shares, strong sales and increased operating profit

Aros Bostadsutveckling AB publ (”Aros Bostad”) has published the six month report for January to June 2021. For Aros Bostad, the reporting period contained high activity and good sales in a strong residential market. During the second quarter, the company listed its ordinary shares at OMX Nasdaq First North, thereby enabling a higher pace in the development of wholly-owned residential development projects. Further, additional building rights were acquired during the second quarter and two development projects were divested as rental apartment projects to institutional investors after the

Ingrid welcomes Slöjd-Detaljer as a new client

We're excited to welcome Slöjd-Detaljer as our new client! Slöjd-Detaljer was founded in 1960 by Dan and Margit Medin. Back then, the main focus of the company was to provide schools with supplies for woodwork classes. Although the customer base, product range, catalogue and market has altered and expanded over the years, the basic business idea has remained unaltered—creativity and the joy of creating remains as Slöjd-Detaljer's core focus. By optimizing the delivery experience, Ingrid helps modern e-commerce companies turn a former pain point into a competitive advantage.

BAKKAFROST: Share Savings Plan Transaction

As a part of the share savings plan for employees in 2021, the following primary insiders have purchased Bakkafrost shares: · Regin Jacobsen, CEO, purchased 37 shares. After the transaction, he holds 4,617,264 shares. · Høgni Dahl Jakobsen, CFO, purchased 22 shares. After the transaction, he holds directly and indirectly 74,450 shares. · Odd Eliasen, Managing Director, purchased 60 shares. After the transaction, he holds 184,899 shares. · Annika Frederiksberg, Board Member, purchased 10 shares. After the transaction, she holds directly and indirectly 16,226 shares. The

SynAct Pharma Provides an Update on Patient Recruitment in the Phase 2a Clinical Trial of AP1189 in Rheumatoid Arthritis

SynAct Pharma AB (“SynAct”) today announced that recruitment in the BEGIN study in Rheumatoid Arthritis (RA) has been extended into the first half of September in order to reach the goal of 105 randomized patients, of which 98 have been recruited to date. As a result of the continued recruitment, reporting of key results previously expected to take place by the end of Q3 will be postponed to early Q4 after which a press release with top-line results will be released immediately. SynAct applauds the efforts of its clinical sites and their patients to keep this important evaluation of AP1189

Drones delivered defibrillators to patients with suspected cardiac arrests

Researchers at Karolinska Institutet in Sweden can now report the results of a unique pilot project where drones were used to deliver defibrillators to real-life alerts of suspected cardiac arrest. The drones were dispatched in more than a fifth of the emergencies and arrived on target and ahead of the ambulance in most cases. The results are published in the European Heart Journal and presented today at the European Society of Cardiology congress.”This is the first time in the world that a research group can report results from a study where drones flew defibrillators to location of real-

Dooba Finance AB (publ) – Publishing of the Quarter End Report for Q2 2021

On 27 October 2020, Dooba Finance AB (publ) (the “Company”) issued senior unsecured bonds in an amount of SEK 500.5 million guaranteed by Dooba Holdings Limited (the “Bonds”). On 22 March 2021, Dooba Finance AB (publ) (the “Company”) issued senior unsecured bonds in an amount of SEK 99 million under its existing framework of up to SEK 600 million senior unsecured bonds due 2024 (ISIN: NO0010895360) (the “Subsequent Bonds”).The Company today announces the publication of its Quarter End Report for Q2 2021. The report can be found at https://dfabbond.se/

Prostatype Genomics AB intends to carry out a directed share issue of approximately SEK 24 million

- Prostatype Genomics AB (“Prostatype” or “the Company”) hereby announces that the Company intends to carry out a directed share issue of approximately SEK 24 million to Swedish and international investors. The Company has assigned Sedermera Fondkommission to act as bookrunner in connection with the directed share issue. The capital raise is intended to finance activities carried out within the previously announced agreement with Proteomedix AG (“Proteomedix”).Cooperation with Proteomedix Proteomedix develops a next generation blood test for prostate cancer. The product complements

There are no items matching the current filter
There are no more items matching the current filter
Back to top